Expert Talk
Securing the Pharma Supply Chain: Insights on Secondary Packaging from INTERPHEX 2026
What stood out to me at INTERPHEX was the stronger connection between manufacturing quality logistics and distribution Packaging is increasingly seen as part of the broader control strategy
Unlocking the Next Era of Pharmaceutical Innovation Through AI
Artificial Intelligence is shifting pharmaceutical innovation from empirical development to a more predictive and datadriven discipline Traditionally drug development has relied on sequential experimentation
Driving Global Life Sciences Collaboration Through UK Biotech Day 2026
In this exclusive interview Asad Ali Senior Executive Director at UK Biotech Day discusses how UK Biotech Day is positioning itself as a global platform for biotech collaboration investment innovation and strategic partnerships while addressing key industry challenges shaping the future of life sciences
Decoding Tumors: Bridging Nanotechnology and AI for Next-generation Pharmaceutical Development and Precision Medicine
In our recent review we have highlighted the ability of AIintegrated aptamerbased nanosensors in transforming the pharmaceutical landscape
Long-Term Safety of Combination Products Incorporating Emerging Platform Technologies: Considerations for Gene Therapies, Immuno-Oncology Platforms, and Other Novel Modalities
Advanced modalities are reshaping longterm safety expectations by extending the risk horizon beyond early tolerability and shortterm adverse event review Gene therapies immunooncology platforms and other novel technologies may introduce delayed persistent immunemediated or cumulative toxicities that emerge
Learning Faster Than the Problem: Building High-Performance Technical Teams Across Pharma's Operating Realities
Let me put it the way I see it on the ground An innovative biotech team is building knowledge about a single molecule that may define the companys future A CDMO team runs a portfolio of compounds simultaneously
Make Quality a Strategic Business Driver
Organisations need to move beyond narrow cost of compliance metrics and adopt an enterprise wide Cost of Quality CoQ approach that captures both direct and indirect impacts This includes not only the obvious costs
How Quality Leaders Prevent Issues from Becoming Business Risks
A small quality gap is rarely just a local issue And it runs the risk of becoming more dangerous when organisations assess it locally instead of systemically The real question is not only what happened
The Largest Global Life Sciences Supply Chain Event
The event has evolved at the same pace as the industry and the technology supporting the industry has evolved Supply Chain and Logistics solutions today offer global monitoring and intervention at a level we could only dream about years ago The pace of the change and the willingness of the industry to be bold in implementing those changes is what...
Nanotechnology in Therapeutics. Basics and Trends
Nanotechnology has evolved from a research topic into a cornerstone of drug delivery diagnostics and personalised
